Lipid News

A deeper insight into phospholipid biosynthesis in Gram-positive bacteria

Diego E Sastre Marcelo E Guerin
By Diego E Sastre and Marcelo E Guerin
Feb. 18, 2020

Gram-positive bacteria can cause serious and sometimes fatal inflammatory diseases including skin infections, pharyngitis, pneumonia, endocarditis, myocarditis, meningitis, rheumatic fever and septicemia. These bacteria synthesize phosphatidic acid, the central precursor of membrane phospholipids, using an unusual acyl-phosphate intermediate in a three-step pathway mediated by three phospholipid synthesis enzymes: PlsX, PlsY and PlsC. 

Diego Sastre
This schematic representation shows binding/insertion of PlsX to lipid bilayers.

PlsX is a peripheral membrane transacylase that catalyzes the conversion of acyl-acyl carrier protein to acyl-phosphate and helps coordinate fatty acid and phospholipid biosynthesis. PlsX binds and inserts directly to lipid bilayers, a process mediated by an amphipathic four alpha-helical bundle subdomain that protrudes from the main core of the enzyme.

In disentangling this binding and insertion of PlsX, our lab has found that PlsX membrane binding is mediated by phospholipid charge, whereas unsaturation of fatty acids and membrane fluidity influence membrane insertion. Superficial access to the membrane is not sufficient to ensure efficient delivery of the acyl-phosphate from PlsX to the acyltransferase partner PlsY, which depends on proper and stable insertion of PlsX in the membrane. Such substrate channeling can make this metabolic pathway more efficient and prevents the release of unstable intermediates, protecting them from decomposition and/or diffusion through the aqueous cytoplasm. 

In a recent paper in the Journal of Biological Chemistry, we propose a model in which membrane fluidity governs the membrane insertion of PlsX, which is required for the proper acyl-phosphate delivery to PlsY. 

Our model breaks a paradigm in membrane biology, because the membrane fluidity and unsaturated fatty acids, or UFAs, do not seem to be holding hands. At higher membrane fluidity, PlsX inserts deeper into the membrane, but increased UFA content reduces PlsX binding and insertion. 

How can PlsX sense the UFAs, and why do UFAs repel PlsX binding and insertion? We suspect the repulsion effect might be part of a mechanism to downregulate the total phospholipid synthesis observed at low growth temperature. 

In membrane insertion, peripheral proteins can cluster as transient oligomers when interacting with lipid bilayers. This crowding would be intensified with increased protein radius and depth of penetration into the hydrophobic region of the membrane. PlsX mostly is distributed homogenously at the bacterial cell membrane, but PlsX foci also are transiently and randomly observed, which could represent physiological oligomeric states related to the regulation of PlsX activity.

We propose that PlsX inserts deeper into more fluid membranes (containing little or no unsaturated fatty acid content), causing oligomers, including other partners, in the form of foci at the membrane. Thus, modulating membrane insertion could regulate the substrate channeling as well as the protein crowding, regulating the phospholipid biosynthesis.

These results highlight the relevance of spatial organization for metabolic pathway functioning and tell us more about how membrane composition and protein mobility can modulate this biosynthesis route. PlsX and PlsY are present in pathogenic bacteria and absent in eukaryotes, so the results offer exciting possibilities for inhibitor design to fight antibiotic-resistant bacteria.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Diego E Sastre
Diego E Sastre

Diego Sastre recently has been hired as an assistant research scientist in the Sundberg lab in the department of biochemistry at the Emory University School of Medicine.
 

Marcelo E Guerin
Marcelo E Guerin

Marcelo Guerin is an Ikerbasque full research professor and head of the structural glycobiology laboratory at the Structural Biology Unit of the Center for Cooperative Research in Biosciences in Derio, Spain.
 

Related articles

Arginine tango
Nicole Lynn
At the interface
Lina M. Obeid & Michael J. Pulkoski-Gross
Unexpected roles of lipid kinases
Kaoru Goto & Toshiaki Tanaka
Back to the (poly)basics
Salome Boroda & Thurl Harris
Elusive zebrafish enzyme in lipid secretion
Isabel Casas & Emily Ulrich

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Mapping the placenta’s hormone network
Journal News

Mapping the placenta’s hormone network

Oct. 21, 2025

Study uncovers how the placenta actively metabolizes not only glucocorticoids but also novel androgens and progesterones, reshaping our understanding of pregnancy and its complications.

Biochemists and molecular biologists sweep major 2025 honors
News

Biochemists and molecular biologists sweep major 2025 honors

Oct. 20, 2025

Recent Nobel, MacArthur and Kimberly Prize honorees highlight the power of biochemistry and molecular biology to drive discovery, including immune tolerance, vaccine design and metabolic disease, and to advance medicine and improve human health.

Spider-like proteins spin defenses to control immunity
News

Spider-like proteins spin defenses to control immunity

Oct. 17, 2025

Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.

A biological camera: How AI is transforming retinal imaging
Feature

A biological camera: How AI is transforming retinal imaging

Oct. 15, 2025

AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.